Construct: ORF ccsbBroadEn_14923
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF018868.1_s300c1, BRDN0000458164
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- Early stop codon detected
Originally Annotated References:
- Gene:
- BRSK2 (9024)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | NM_003957.4 | 96.5% | 37.1% | (many diffs) |
| 2 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | NM_001256629.2 | 93.4% | 36.7% | (many diffs) |
| 3 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_005253218.3 | 88.7% | 34.4% | (many diffs) |
| 4 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | NM_001256627.2 | 87.5% | 33.6% | (many diffs) |
| 5 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_006718374.2 | 85.5% | 32.7% | (many diffs) |
| 6 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | NM_001282218.2 | 84.7% | 27.8% | (many diffs) |
| 7 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | NM_001256630.1 | 81.9% | 29.8% | (many diffs) |
| 8 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_011520462.2 | 80.5% | 26.1% | (many diffs) |
| 9 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_011520461.2 | 79.4% | 25.5% | (many diffs) |
| 10 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_006718376.2 | 77.7% | 24.8% | (many diffs) |
| 11 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_017018536.1 | 76.1% | 28.9% | (many diffs) |
| 12 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_017018533.1 | 74.6% | 28.1% | (many diffs) |
| 13 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_017018537.1 | 73.7% | 23.1% | (many diffs) |
| 14 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_017018535.1 | 69.1% | 21.9% | (many diffs) |
| 15 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_017018534.1 | 68.6% | 21.7% | (many diffs) |
| 16 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_017018532.1 | 67.9% | 21.3% | (many diffs) |
| 17 | human | 84446 | BRSK1 | BR serine/threonine kinase 1 | NM_032430.2 | 65.2% | 30.3% | (many diffs) |
| 18 | human | 84446 | BRSK1 | BR serine/threonine kinase 1 | XM_024451739.1 | 60.2% | 23.9% | (many diffs) |
| 19 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XR_930925.1 | 49.8% | (many diffs) | |
| 20 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XR_242831.2 | 49.3% | (many diffs) | |
| 21 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XR_002957207.1 | 49.2% | (many diffs) | |
| 22 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | NR_046331.2 | 46.8% | (many diffs) | |
| 23 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XR_001748025.1 | 45.5% | (many diffs) | |
| 24 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XR_930926.2 | 44.5% | (many diffs) | |
| 25 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XR_001748026.2 | 41.1% | (many diffs) | |
| 26 | human | 9024 | BRSK2 | BR serine/threonine kinase 2 | XM_017018538.1 | 40.4% | 2.8% | (many diffs) |
| 27 | mouse | 75770 | Brsk2 | BR serine/threonine kinase 2 | NM_029426.2 | 83.1% | 37.6% | (many diffs) |
| 28 | mouse | 75770 | Brsk2 | BR serine/threonine kinase 2 | NM_001009929.3 | 82.7% | 36.4% | (many diffs) |
| 29 | mouse | 75770 | Brsk2 | BR serine/threonine kinase 2 | NM_001276763.1 | 81.7% | 36.4% | (many diffs) |
| 30 | mouse | 75770 | Brsk2 | BR serine/threonine kinase 2 | NM_001009930.3 | 78.8% | 34.2% | (many diffs) |
| 31 | mouse | 381979 | Brsk1 | BR serine/threonine kinase 1 | NM_001168572.1 | 37.1% | 68.5% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 98
- ORF end:
- 845
- ORF length:
- 747
- Sequence:
-
1 ACGGATTTTA TTTTGACTGA TAGTGACCTG TTCGTTGCAA CAAATTGATG AGCAATGCTT 61 TTTTATAATG CCAACTTTGT ACAAAAAAGT TGGCACCATG ACATCGACGG GGAAGGACGG 121 CGGCGCGCAG CACGCGCAGT ATGTTGGGCC CTACCGGCTG GAGAAGACGC TGGGCAAGGG 181 GCAGACAGGT CTGGTGAAGC TGGGGGTTCA CTGCGTCACC TGCCAGAAGG TGGCCATCAA 241 GATCGTCAAC CGTGAGAAGC TCAGCGAGTC GGTGCTGATG AAGGTGGAGC GGGAGATCGC 301 GATCCTGAAG CTCATTGAGC ACCCCCACGT CCTAAAGCTG CACGACGTTT ATGAAAACAA 361 AAAATATTTG TACCTGGTGC TAGAACACGT GTCAGGTGGT GAGCTCTTCG ACTACCTGGT 421 GAAGAAGGGG AGGCTGACGC CTAAGGAGGC TCGGAAGTTC TTCCGGCAGA TCATCTCTGC 481 GCTGGACTTC TGCCACAGCC ACTCCATATG CCACAGGGAT CTGAAACCTG AAAACCTCCT 541 GCTGGACGAG AAGAACAACA TCCGCATCGC AGACTTTGGC ATGGCGTCCC TGCAGGTTGG 601 CGACAGCCTG TTGGAGACCA GCTGTGGGTC CCCCCACTAC GCCTGCCCCG AGGTGATCCG 661 GGGGGAGAAG TATGACGGCC GGAAGGCGGA CGTGTGGAGC TGCGGCGTCA TCCTGTTCGC 721 CTTGCTGGTG GGGGCTCTGC CCTTCGACGA TGACAACTTG CGACAGCTGC TGGAGAAGGT 781 GAAGCGGGGC GTGTTCCACA TGCCGCACTT TATCCCGCCC GACTGCCAGA GTCTGCTACG 841 GGCATGATCG AGGTGGACGC GGCACGCGCT CACGCTAGAG CACATTCAGA CCACatatgg 901 tatatagggg gcaagaatga gcccgaacca gagcagccca ttcctcgcaa ggtgcagatc 961 cgctcgctgc ccagcctgga ggacatcgac cccgacgtgc tggacagcat gcactcactg 1021 ggctgcttcc gagaccgcaa caagctgctg caggacctgc tgtccgagga ggagaaccag 1081 gagaagatga tttacttcct cctcctggac cggaaagaaa ggtacccgag ccaggaggat 1141 gaggacctgc ccccccggaa cgagatagac cctccccgga agcgtgtgga ctccccgatg 1201 ctgaaccggc acggcaagcg gcggccagaa cgcaaatcca tggaggtgct cagcgtgacg 1261 gacggcggct ccccggtgcT TGCGCGGGGC CCATCCCCCA ATTTACGCAA GGAAGAAAGT 1321 TTTTGGGTTC CTTAAAGGGG GCTTCCTTGA GGCTTTTCCC ACCAGCCCCA TCCAGGAGGC 1381 CCCCGGGGGG CCCCCTTAAC CCCTTCCACC AAGGGCCATT CCCCCCTCCC CCCCCCCCCC 1441 CAGGGACACC TGTCCACACG CCAAAGGAGA GCCCGGCTGG CACGCCCAAC CCCCAAGGCC 1501 CCCGTCCAGC CCCAGCGTCG GAGGGGTGCC CTGGAGGGCG CGGCTCAACT CCATCAAGAA 1561 CAGCTTTCTG GGCTCACCCC GCTTCCACCG CCGGAAACTG CAAGTTCCGA CGCCGGAGGA 1621 GATGTCCAAC CTGACACCAG AGTCGTCCCC AGAGCTGGCG AAGAAGTCCT GGTTTGGGAA 1681 CTTCATCAGC CTGGAGAAGG AGGAGCAGAT CTTCGTGGTC ATCAAAGACA AACCTCTGAG 1741 CTCCATCAAG GCTGACATCG TGCACGCCTT CCTGTCGATT CCCAGTCTCA GCCACAGCGT 1801 CATCTCCCAA ACGAGCTTCC GGGCCGAGTA CAAGGCCACG GGGGGGCCAG CCGTGTTCCA 1861 GAAGCCGGTC AAGTTCCAGG TTGATATCAC CTACACGGAG GGTGGGGAGG CGCAGAAGGA 1921 GAACGGCATC TACTCCGTCA CCTTCACCCT GCTCTCAGGC CCCAGCCGTC GCTTCAAGAG 1981 GGTGGTGGAG ACCATCCAGG CCCAGCTGCT GAGCACACAC GACCCGCCTG CGGCCCAGCA 2041 CTTGTCAGAC ACCACTAACT GTATGGAAAT GATGACGGGG CGGCTTTCCA AATGTGGAAT 2101 TATCCCGAAA AGTTTGCCAA CTTTCTTGTA CAAAGTTGGC ATTATAAGAA AGCATTGCTT 2161 ATCAATTTGT TGCAACGAAC AGGTCACTAT CAGTCAAAAT AAAATCATTA TTGCCATCCA 2221 AGCTGATATC